Stockwinners Market Radar for August 05, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

17:19 EDT Uranium Energy confirms intention to acquire UEX Corporation - Uranium Energy (UEC) announces that, further to its news release of July 28, it has advised UEX Corporation that it is submitting a superior offer to the acquisition proposal made by Denison Mines (DNN) on July 28 for all of the issued and outstanding shares of UEX. Under the terms of UEC's revised offer, each holder of UEX Shares will now receive 0.0890 of one common share of UEC for each UEX Share held, implying consideration of approximately C$0.49 per UEX Share based on the closing price of UEX Shares and UEC Shares on the Toronto Stock Exchange and the NYSE American Exchange, respectively, and the spot exchange rate as of August 5. The Revised UEC Offer also increases the break fee by 7%, which is an increase proportional to the percentage increase in the offered exchange ratio under the Revised UEC Offer. Amir Adnani, President and CEO, stated: "After careful analysis and consideration, we firmly believe the Revised UEC Offer represents a value-creating opportunity for UEC and UEX shareholders. We remain disciplined with respect to pursuing accretive growth and the Revised UEC Offer strikes a balance of a modest increase in the exchange ratio while doubling UEC's uranium resources1 at only a 14.2% dilution to our outstanding shares. This transaction highlights UEC's sector leading strategy as the fastest growing, pure play, 100% unhedged uranium company and will create the largest, diversified North American focused uranium company. Finally, a true testament to the win-win industrial logic of the transaction is the overwhelming positive support for our deal, as evidenced with over 38% of eligible UEX securities tendered with over 93.7% voted in favor, and the positive share price performance for UEC. With an offer that is superior to the Denison Proposal in all respects, we look forward to completing this transaction following the UEX shareholder vote next week." If the board of directors of UEX accepts the Revised UEC Offer, UEC expects that the special meeting of UEX securityholders to approve UEC's acquisition of the UEX Shares based on the Revised UEC Offer will continue to be held as currently scheduled on Tuesday August 9, with an anticipated closing date by mid-August.

17:06 EDT Gartner exec Dawkins sells 3,332 common shares - In a regulatory filing, Gartner executive VP of Global Business Sales Alwyn Dawkins disclosed the sale of 3,332 common shares of the company on August 3 at a price of $295 per share.

16:56 EDT Cano Health names Bob Camerlinck as COO, Amy Charley as CAO - Cano Health announced two new senior positions on its executive leadership team to build on its success and help drive critical opportunities for a stronger professional infrastructure across the organization. Bob Camerlinck, President of Cano Health's Healthy Partners Medical Centers and Affiliates, will become COO, and Amy Charley will join the company as Chief Administrative Officer, effective August 1. Previously serving as President of Healthy Partners Medical Centers and Affiliates, Camerlinck has over 25 years of extensive experience in value-based care, introducing comprehensive Medicare Advantage health plans to primary care physicians and supporting physicians in value-based healthcare systems. Charley joins Cano Health from Alteon Health, where she served as Chief Legal and Administrative Officer.

16:47 EDT AnPac Bio names Yuyang Cui co-chairman, co-CEO - AnPac Bio-Medical Science Co. announced that effective August 2, 2022, the board of directors appointed Jiawen Kang as a member of the board of directors of the company and a member of the Audit Committee and Nominating Committee. On that date, the company also appointed Yuyang Cui as a Co-Chairman of the Board and Co-Chief Executive Officer of the company. As Co-CEO of the company, Yuyang Cui will be primarily responsible for searching and presenting potential business opportunities to the Company and the Board as well as the capital markets strategy and related activities for AnPac Bio. Chris Chang Yu has since been re-designated as the Co-Chief Executive Officer of the company, with primary responsibilities for the general operations and all related businesses except for the duties that are outlined for Cui.

16:31 EDT Kodiak Sciences completes enrollment in GLOW trial - Kodiak Sciences announced that it has completed enrollment in its GLOW Phase 3 clinical trial of tarcocimab tedromer, Kodiak's anti-VEGF antibody biopolymer conjugate, in patients with Non-Proliferative Diabetic Retinopathy without diabetic macular edema.

16:20 EDT Tesla confirms three-for-one stock split - Tesla announced that the Board of Directors has approved and declared a three-for-one split of Tesla's common stock in the form of a stock dividend to make stock ownership more accessible to employees and investors. Each stockholder of record on August 17 will receive a dividend of two additional shares of common stock for each then-held share, to be distributed after close of trading on August 24. Trading will begin on a stock split-adjusted basis on August 25.

16:13 EDT Havertys announces new $25M stock repurchase program - The board approved a new authorization under its stock repurchase program that permits the company to purchase up to $25M of its common stock and Class A common stock. Shares may be repurchased, at the company's discretion, from time-to-time in the open market or in privately negotiated transactions.

15:01 EDT General Dynamics NASSCO awarded $1.4B to build U.S. Navy ships - General Dynamics NASSCO, a subsidiary of General Dynamics, announced that it received $1.4B in U.S. Navy contract modifications for construction of a sixth Expeditionary Sea Base ship and two additional John Lewis-class fleet oilers. This award comes in addition to $600M already received to procure long-lead time materials for the same ships. The contract modification also provides an option for the Navy to procure an additional oiler, T-AO 213, bringing the total potential value to $2.7B for the four ships, the company said.

14:08 EDT Applied DNA Sciences trading resumes

14:03 EDT Applied DNA Sciences trading halted, volatility trading pause

13:02 EDT Baker Hughes reports U.S. rig count down 3 to 764 rigs - Baker Hughes reports that the U.S. rig count is down 3 from last week to 764 with oil rigs down 7 to 598, gas rigs up 4 to 161 and miscellaneous rigs unchanged at 5. U.S. Rig Count is up 273 rigs from last year's count of 491 with oil rigs up 211, gas rigs up 58 and miscellaneous rigs up 4. The U.S. Offshore Rig Count is down 1 to 16, up 2 year-over-year. The Canada Rig Count is down 1 from last week to 203, with oil rigs up 3 to 140, gas rigs down 4 to 63. The Canada Rig Count is up 47 rigs from last year's count of 156, with oil rigs up 45, gas rigs up 3 and miscellaneous rigs down 1.

12:54 EDT FDA approves Bayer darolutamide tablets for prostate cancer - The Food and Drug Administration said it approved Bayer HealthCare Pharmaceuticals' darolutamide tablets in combination with docetaxel for adult patients with metastatic hormone-sensitive prostate cancer. Reference Link

12:35 EDT American Public Education appoints Craig MacGibbon as CIO - American Public Education announced it has appointed Craig MacGibbon as its Executive Vice President and Chief Information Officer. In this role, MacGibbon will lead the organization's software development, cybersecurity, enterprise project management, enterprise architecture, infrastructure, and IT service delivery to support of all of APEI's educational units, including American Public University System, Rasmussen University, Hondros College of Nursing, and Graduate School USA. For the past 18 months, MacGibbon has been delegate Chief Technology Officer with APEI while also serving as partner at Wavestone US.

12:01 EDT Illinois Tool Works raises quarterly dividend 7% to $1.31 per share - The Board of Directors of Illinois Tool Works authorized a seven percent increase to the dividend payout to shareholders, representing a quarterly increase of 9c per share - or 36c per share annually - versus the current dividend rate. The Board also declared a dividend on the company's common stock of $1.31 per share for the third quarter of 2022. The dividend equates to $5.24 per share on a full-year basis. The dividend will be paid on October 14, 2022 to shareholders of record as of September 30, 2022.

12:00 EDT Virgin Galactic falls -15.6% - Virgin Galactic is down -15.6%, or -$1.27 to $6.92.

12:00 EDT BigBear.ai rises 27.0% - BigBear.ai is up 27.0%, or 65c to $3.06.

12:00 EDT Cooper-Standard rises 72.8% - Cooper-Standard is up 72.8%, or $3.66 to $8.69.

11:43 EDT Fulcrum Therapeutics up 8% after WSJ says Pfizer in talks to buy Global Blood

11:34 EDT Global Blood Therapeutics trading halted, volatility trading pause

11:15 EDT Pulmatrix trading resumes

10:16 EDT Carvana trading resumes

10:01 EDT Cinedigm acquires 'Roy's World: Barry Gifford's Chicago' documentary - Cinedigm has acquired all North American rights to the documentary Roy's World: Barry Gifford's Chicago, about the life of cult author and David Lynch collaborator Barry Gifford. After premiering at the Glasgow Film Festival before screening all over the world, Roy's World premieres on transactional video on demand and on Cinedigm's indie discovery platform Fandor on October 18.

10:00 EDT Twilio falls -17.4% - Twilio is down -17.4%, or -$17.07 to $81.12.

10:00 EDT Cloudflare rises 16.4% - Cloudflare is up 16.4%, or $9.59 to $68.02.

10:00 EDT Cooper-Standard rises 68.0% - Cooper-Standard is up 68.0%, or $3.42 to $8.45.

09:47 EDT Doximity falls -15.2% - Doximity is down -15.2%, or -$6.13 to $34.18.

09:47 EDT Virgin Galactic falls -18.2% - Virgin Galactic is down -18.2%, or -$1.49 to $6.70.

09:47 EDT Atlas Corp. rises 23.1% - Atlas Corp. is up 23.1%, or $2.67 to $14.24.

09:47 EDT Cooper-Standard rises 49.1% - Cooper-Standard is up 49.1%, or $2.47 to $7.50.

09:42 EDT Kaspien Holdings Inc trading resumes

09:39 EDT Cellect Biotechnology Ltd - ADR trading halted, volatility trading pause

09:37 EDT WeTrade Group Inc trading resumes

09:35 EDT Exagen trading resumes

09:35 EDT Save Foods Inc trading resumes

09:33 EDT EJF Acquisition Corp trading halted, volatility trading pause

09:32 EDT WeTrade Group Inc trading halted, volatility trading pause

09:31 EDT Sweetgreen opens first location in Michigan - On Tuesday, August 9, sweetgreen will open its first Michigan location in Birmingham, the 170th location for the restaurant brand. Guests can visit the new location at 167 North Old Woodward Avenue, a community that is enriched with local pride and holds a deep appreciation for healthy, sustainable food options.

09:30 EDT Eiger BioPharmaceuticals trading halted, volatility trading pause

09:24 EDT Planet Green Holdings CEO buys $1.4M in common stock - In a regulatory filing, Planet Green Holdings disclosed that its CEO Bin Zhou bought 880K shares of common stock on July 27th in a total transaction size of $1.4M. Shares of Planet Green Holdings are up 12.5% in pre-market trading at 92c per share.

09:17 EDT A2Z Smart Technologies nominates Gadi Graus to Cust2Mate board - A2Z Smart Technologies announced that it has nominated Gadi Graus to the Board of Directors of its wholly owned subsidiary, Cust2Mate Ltd. Mr. Graus currently serves as a senior partner at Shibolet & Co., a leading law firm in Israel. A2Z also announced, that the Company has granted 1,265,000 Restricted Share Units to directors, officers and advisers, of which 590,000 RSU's are to executives and directors, pursuant to the Company's RSU Plan and in acknowledgment of the Company's management recent success and increased future workload. The RSUs will vest at each recipient's discretion and taking into account personal tax implications and convert into 1,265,000 common shares of no par value in the Company. In addition, the Company announces that it has granted a director of the Company, options to subscribe for up to 900,000 Common Shares at a price of CAD$3.56 per Common Share. 225,000 Options vest immediately, and the remainder in six equal installments every 6 months with the first installment on February 2, 2023. The options are exercisable for a period of 10 years from the date of issue. About A2Z Smart Technologies Corp

09:13 EDT WeTrade enters partnership for monkeypox test kits and antigen tests - WeTrade announced a strategic partnership with Jiqing Biomedical. The two companies plan to produce and provide exclusive sale channels for monkeypox virus test kits and antigen tests worldwide, aiming to develop domestic and international markets. Jiqing is a biotechnology company focusing on medical research and experimental development. During the pandemic, the antigen self-test kit developed by Jiqing was fully approved by EU, and now Jiqing antigen products have obtained product registration certificates from dozens of countries such as Thailand FDA, UK MHRA, EU CE, Germany Bfarm, Netherlands CIBG, Malaysia MDA, Cambodia, Indonesia, Philippines, etc. The products are exported to more than 60 countries and regions internationally. The bio research and development team of Jiqing has urgently developed two monkeypox virus detection kits: nucleic acid test and antigen test.

09:10 EDT Planet 13 Holdings announces purchase option for Illinois dispensary - Planet 13 Holdings announces that Planet 13 has entered into an Option Purchase Agreement that gives Planet 13 the option to purchase 51% of Planet 13 Illinois from Frank Cowan for $866,250 in cash and 1,063,377 common shares of Planet 13 valued at $2M based on a 5-day VWAP. Should Planet 13 exercise the option, the Planet 13 Shares would be subject to a four-month and one day hold period under Canadian securities laws and a minimum of six months following the date of issuance for resales under Rule 144 promulgated under the U.S. Securities Act of 1933, and following such six month period would be subject to a lock-up whereby 1/12 of the Planet 13 Shares would be released each month thereafter in accordance with a lock up agreement. The option is exercisable at Planet 13's discretion for a period of two years, subject to approval from applicable regulators. However, in accordance with regulatory guidance, the option shall not be exercised prior to Planet 13 Illinois obtaining an Adult Use Dispensing Organization License from the State of Illinois. Planet 13 Illinois is currently 51% owned by Frank Cowan and 49% owned by Planet 13.

09:05 EDT Motorsport Games, BTCC announce 'BTCC rFactor 2 Hot Lap Challenge' - Motorsport Games, in conjunction with the British Touring Car Championship, announces the BTCC rFactor 2 Hot Lap Challenge. The challenge will be available for fans to participate in at the final four race weekends of the 2022 BTCC season. Visitors who also register for the Motorsport Games/BTCC mailing list will be among the first to receive exclusive news and updates on the upcoming BTCC game, slated for full release in 2024.

09:04 EDT L.B. Foster announces track components business divestiture - L.B. Foster announced the sale of its rail spikes and anchors track components business located in St-Jean-sur-Richelieu, Quebec, Canada to Gerdau Ameristeel Corporation located in Whitby, Ontario, Canada. Cash proceeds from the transaction are expected to total approximately $7.8M, subject to customary indemnification obligations and working capital adjustment. Revenues from the divested Business totaled approximately $14M for the trailing-twelve-months ended June 30, 2022. John Kasel, the Company's President and Chief Executive Officer, commented, "The sale of the track components business represents another accomplishment along our strategic transformation journey. We're pleased with the outcome of the process and satisfied that the business will be operated by a well-respected industry player. Proceeds from the sale will be used to pay down our revolving credit facility and further enable our ability to execute on our growth playbook initiatives."

09:01 EDT BeMetals announces $5M funding from B2Gold - BeMetals announces that it has entered into a loan agreement with strategic investor B2Gold Corp. for an unsecured loan in the principal amount of US$5,000,000. The Loan matures on August 4, 2025 and bears interest at a rate of 4.7% per annum. The interest on the Loan is to be paid or accrued annually at the discretion of the Company and the Loan is repayable in part or in full at any time without penalty. The Loan will be used for general working capital. The Company is not issuing any securities or paying any bonuses, commissions or finder's fees with regards to the Loan.

08:46 EDT Kazia Therapeutics' paxalisib shows 100% response in brain metastases trial - Kazia Therapeutics presented "promising" new data from an ongoing phase I clinical trial of paxalisib in combination with radiotherapy for the treatment of brain metastases. Interim data from the first stage of the study reports that all 9 evaluable patients experienced complete or partial response, representing an overall response rate of 100%. For comparison, a typical ORR associated with whole brain radiotherapy alone can commonly range from 20-45% in published studies. The data has been accepted for an oral presentation at the upcoming 2022 Annual Conference on CNS Clinical Trials and Brain Metastases from 12-13 August. This clinical trial that is examining the combination of paxalisib with whole brain radiotherapy for patients with brain metastases. 9 of 12 patients in the initial stage were evaluable for efficacy. All 9 patients exhibited complete or partial response. The patients comprised a range of primary tumours, with breast cancer the most common, representing one third of patients. The safety profile of paxalisib in combination was broadly consistent with monotherapy experience in other clinical trials. Recruitment to the expansion stage has already commenced, with the objective of recruiting an additional 12 patients.

08:37 EDT Calumet announces Warburg Pincus agrees to invest $250M in Montana Renewables - Calumet Specialty Products Partners announced a series of transactions conducted by its unrestricted subsidiary Montana Renewables, or "MRL," a renewable fuel business. Global growth investor Warburg Pincus has agreed to invest $250M in MRL in the form of a participating preferred equity security, which values MRL at a pre-commissioning enterprise value of $2.25B. The preferred equity investment is not interest-bearing and carries certain minimum return thresholds. In connection with the investment, Warburg Pincus will have a representative on MRL's four-member board of managers. Calumet also announced that Stonebriar Commercial Finance has invested an additional $350M through a pair of sale and leaseback contracts on top of its existing $50M commitment to MRL. The sale and leaseback transactions carry an approximate 12.3% cost of capital and offer certain strategic early termination options. Concurrent with these transactions, the $300M convertible investment from Oaktree Capital Management L.P. in MRL has been retired. "Today's transactions are accretive in the aggregate. MRL's pro forma liquidity, after giving effect to these transactions, is approximately $300M," the company said. "This investment will accelerate our mission to quickly produce low-emission alternatives that directly replace fossil fuel products. We are pleased to partner with Warburg Pincus, a world class institutional investor, as well as to extend our longstanding multi-site relationship with Stonebriar. We would also like to extend our gratitude to Oaktree for their initial investment in MRL. Oaktree's alignment and support of our vision allowed the launch of this business in 2021. Today's announcement of increased capitalization further solidifies MRL's go-forward business plan to increase capacity in 2024-25 to an estimated 18,000 barrels per day, including the optionality to convert a large portion of the plant's production from RD to SAF," " said Bruce Fleming, EVP Montana Renewables and Corporate Development. Calumet will continue to market the potential share sale to strategic and other investors via the formal process being conducted by Lazard, the company noted.

08:36 EDT Ebang to launch Ebonex crypto-linked payment cards powered by MasterCard - Ebang International announced that its Australian cryptocurrency exchange platform, Ebonex, has collaborated with Mastercard to enable a new crypto-linked card. Ebonex allows customers to buy, sell and trade crypto assets. This collaboration with Mastercard will give Ebonex customers the flexibility to spend their crypto holdings anywhere Mastercard is accepted by seamlessly converting it into fiat currency the merchant accepts. With this collaboration, Ebonex becomes the first Australian cryptocurrency exchange to be granted Mastercard's Principal Member status for issuance of crypto-funded Mastercard payment cards.

08:36 EDT Delcath Systems' Chemosat system shows efficacy in published study - Delcath Systems announced the publication of a retrospective analysis of patients who underwent a percutaneous hepatic perfusion procedure with Chemosat at three European centers between February 2014 and December 2019. The study involved 101 patients who completed a minimum of one PHP procedure for the treatment of unresectable uveal melanoma - UM - liver metastases. After a median follow-up time of 15 months, a complete response was reported in five - 5.0% - patients; partial response in 55 - 54.5% -, and stable disease in 30 - 29.7% - , resulting in an objective response rate of 59.4% and a disease control rate of 89.1%. The median progression-free survival, liver progression-free survival, and overall survival were 9.0 months; 11.0 months; and 20.0 months, respectively. The study also found statistically significant differences in median PFS, median LPFS, and OS between patients who had CR, PR, or SD; and patients with progressive disease. The most common adverse events were hematological toxicities which were grade 1/2 and self- limiting in the majority of patients and consistent with previous reports on PHP. Other adverse events were thromboembolic in nature. The mortality rate was 1.1% within 30 days after PHP. Declath expects to resubmit the NDA for Hepzato Kit, the combination of the Chemosat device packaged with melphalan, to FDA by the end of Q3.

08:31 EDT Creatd acquires majority stake in Orbit Media, terms not disclosed - Creatd announced that it has completed its purchase of a majority ownership stake in Orbit Media, a new app-based stock trading platform designed to empower a new generation of investors, providing users with a like-minded community as well as access to tools, content, and other resources to learn, train, and excel in the financial markets. Orbit recently concluded its beta testing program and is expected to have its full launch by the end of the year. .

08:29 EDT iRobot trading to resume at 8:30 am ET - Shares of iRobot (IRBT) were halted pending news before the company announced a definitive merger agreement under which Amazon (AMZN) will acquire iRobot for $61 per share in an all-cash transaction valued at approximately $1.7B, including iRobot's net debt. Trading will resume at 8:30 am ET, according to Nasdaq.

08:08 EDT Founder SPAC announces up to $150M forward-purchase agreement - Founder SPAC in connection with its proposed business combination with Rubicon Technologies, announced that it has entered into a forward purchase agreement for up to $150 million with ACM ARRT F LLC.

08:06 EDT Vaxart stockholders approve proxy proposals 2, 3, and 4 - Vaxart announced that at its reconvened Annual Meeting of Stockholders on August 4, its stockholders had voted to approve Proposals 2, 3 and 4. Proposal 2 is an amendment to the Company's Restated Certificate of Incorporation to increase the authorized number of shares of its common stock to 250 million shares. Proposal 3 involved an Amendment and Restatement of the 2019 Equity Incentive Plan. Proposal 4 sought stockholder approval for the 2022 Employee Stock Purchase Plan. Proposals 3 and 4 were contingent on the passage of Proposal 2. While Proposal 2 had previously received strong support from voting stockholders at the initial annual meeting in June, the votes in support of this proposal had not surpassed the 50% of outstanding shares required for it to pass. In the tally Vaxart announced yesterday, Proposal 2 was supported by 82% of the voting shares, with the votes in favor totaling 1.5 million more than the 50% of outstanding shares required for it to pass. "Since our last adjournment, Proposal 2 received 3.4 million additional votes in favor from our investors around the world," said Andrei Floroiu, Chief Executive Officer. "After speaking to many of our investors over the past two months, we have been energized by how passionately they believe in what Vaxart is trying to achieve. I want to thank our stockholders for their support and passion, as well as their strong vote of confidence in our goals and Vaxart's team." With the passage of Proposals 2, 3 and 4, Vaxart's stockholders have approved all six of the 2022 Proposals described in Vaxart's 2022

08:05 EDT Certara announces release 5.2.0 of Pinnacle 21 Enterprise - Certara announced the feature release 5.2.0 of Pinnacle 21 Enterprise, the Company's flagship software for validating clinical trial data for biosimulation and regulatory submissions. It also introduced the new Pinnacle 21 Data Exchange product, an integrated module that streamlines the process of ingesting clinical trial data from external sources.

08:02 EDT Nuvectis Pharma sees cash runway into 2H24 - In August 2022, the Company completed a private placement raising approximately $15.9 million in gross proceeds which is expected to extend the cash runway into H2 2024.

08:02 EDT Amazon to acquire iRobot for $61.00 per share in cash - Amazon (AMZN) and iRobot (IRBT) announced that they have entered into a definitive merger agreement under which Amazon will acquire iRobot. Amazon will acquire iRobot for $61 per share in an all-cash transaction valued at approximately $1.7B, including iRobot's net debt. Completion of the transaction is subject to customary closing conditions, including approval by iRobot's shareholders and regulatory approvals. On completion, Colin Angle will remain as CEO of iRobot.

07:58 EDT Canopy Growth recognized C$1.725B non-cash goodwill impairment charge in Q1 - "The company recognized a non-cash goodwill impairment of C$1.725B related to our cannabis operations reporting unit which is included in our quarterly net loss. This impairment represents the full goodwill balance associated with the cannabis operations reporting unit and was triggered as a result of the decrease in the company's market capitalization in Q1 FY2023."

07:52 EDT Dentsply Sirona says won't file Q2 10-Q by deadline, evaluating adjustments - Last night, Dentsply Sirona gave a business update, stating that as previously disclosed, the Audit and Finance Committee of the company's board is conducting an internal investigation regarding certain financial reporting matters. The investigation is ongoing and therefore the company expects that it will not be in a position to file its Quarterly Report on Form 10-Q for the period ended June 30 by the August 9 deadline. "The Audit Committee continues to work diligently with independent counsel and advisors to complete its previously announced investigation as soon as possible. However, the company cannot predict the duration or outcome of the investigation. Due to the pendency of the investigation, the company has not yet filed its First Quarter 10-Q and does not believe it will file its Second Quarter 10-Q on a timely basis. In the course of the investigation, the company has also evaluated certain other accounting practices. As a result of this review, the company anticipates certain adjustments will be made to the previously announced preliminary first quarter financial results, and the company is currently evaluating whether fiscal year 2021 reported financial results also require adjustments. The company will work to finalize its financial statements and review of internal controls and procedures, including the evaluation of any deficiencies in internal controls over financial reporting, as soon as practicable. As previously disclosed, the company has voluntarily contacted the SEC to advise it that an internal investigation is underway, and the Audit Committee intends to provide additional information to the SEC as its investigation proceeds. The company intends to fully cooperate with the SEC regarding this matter," the company stated.

07:38 EDT E.W. Scripps sees FY22 CapEx $45M-$55M vs. prior view of $70M-$80M

07:34 EDT E.W. Scripps sees FY22 free cash flow $400M vs. prior view of $400-$450M

07:33 EDT BRP Inc. acquires 80% stake in Pinion GmbH, no terms disclosed - BRP Inc. is pleased to announce the acquisition of an 80% stake in Pinion GmbH, a "pioneer" in gearbox technology based in Denkendorf, Germany. Driven by a passion to shape sustainable mobility, Pinion's team of over 60 full-time employees designs, develops, assembles, and sells mechanical gearboxes for traditional and electric bicycles. The company's leading gearboxes are modeled after automobile transmission technology and offer unique cycling dynamics and unparalleled shifting performance. Pinion was founded in 2008 by Christoph Lermen and Michael Schmitz, two automotive engineers. Both Co-Founders and Managing Directors will remain shareholders of Pinion, as will Managing Director and shareholder Thomas Raith. All three leaders will continue to shape the company's path to success and play a key role in its strategic direction alongside Pinion's highly skilled employees. Offices will be maintained in Germany.

07:27 EDT GAP Airports reports July traffic up 20.7% - GAP announces preliminary terminal passenger traffic figures for the month of July, which includes comparisons with the 2019 and 2021 figures to facilitate the reading and understanding of the passenger traffic trend. For July 2022, the total number of terminal passengers at GAP's 12 Mexican airports increased by 18.9%, compared to the same period of 2019. Tijuana, Puerto Vallarta, Los Cabos and Guadalajara presented an increase in passenger traffic of 44.4%, 39.9%, 25.1% and 4.2% respectively, compared to July 2019.

07:25 EDT Hyzon Motors appoints independent board members to investigate certain issues - In a regulatory filing, Hyzon Motors said: "In connection with the preparation of the Company's financial results for the period ended June 30, 2022, the Company's Board of Directors appointed a committee of independent board members to investigate, with the assistance of independent outside counsel and other advisors, certain issues regarding revenue recognition timing and internal controls and procedures, primarily pertaining to its China operations, that were brought to the attention of the Board by Company management. The revenue recognition timing issues being investigated include the recognition of revenue for the year ended December 31, 2021. Due to the ongoing investigation, the Company will be unable to file its Form 10-Q for the quarter ended June 30, 2022 by August 15, 2022, the due date for filing, and does not have an anticipated filing date at this time. The Company will file a Notification of Late Filing on Form 12b-25 on or before August 16, 2022."

07:24 EDT Canopy Growth CFO expects 'cost savings to ramp in the second half of the year' - Judy Hong, CFO: "The cost saving program announced earlier in the quarter combined with sound expense discipline contributed to a meaningful decline in operating expenses during the quarter. We expect cost savings to ramp in the second half of the year, enabling us to execute on our path to profitability even as we continue to invest in strategic growth initiatives including in BioSteel and our U.S. THC ecosystem."

07:23 EDT Hyzon Motors identifies operational ineffeciences at Hyzon Motors Europe JV - In a regulatory filing, Hyzon Motors said: "The Company has identified operational inefficiencies at Hyzon Motors Europe B.V., the Company's European joint venture with Holthausen, which will have a material adverse effect on the Company's ability to produce and sell vehicles. As a result, the Company has determined to restructure its European operations. The Company's Board of Directors has retained a third party consulting firm to assist the Board and management with reassessing the Company's global strategies and operations. The Company has determined to withdraw all financial and operational guidance it has previously issued for all periods, including for the year ended December 31, 2022 and subsequent years."

07:21 EDT Ruth's Hospitality announces new $60M share repurchase program - Subsequent to the end of the second quarter, the company's board of directors approved a new share repurchase program under which it authorized the repurchase of up to $60M of the company's common shares outstanding. The new share repurchase authorization goes into effect on August 9 and does not expire. Share repurchases may be made from time to time in the open market or in negotiated transactions depending on share price, market conditions and other factors. The company had approximately $15.4M remaining under its previous share repurchase authorization, which will be retired on August 8 and replaced by the new share repurchase program.

07:20 EDT Just Energy announces execution of stalking horse transaction agreement - Just Energy Group announced that it has entered into a stalking horse transaction agreement and a support agreement in connection with a proposed sale and investment solicitation process that is intended to facilitate its exit from the company's ongoing insolvency proceedings as a going concern. Upon execution of the SISP Support Agreement, Just Energy and the other parties thereto terminated the previously announced plan support agreement and backstop commitment letter that was entered into in connection with the previously announced proposed plan of compromise and arrangement. Just Energy and certain of its affiliates filed a motion in its proceedings under the Companies' Creditors Arrangement Act before the Ontario Superior Court of Justice on August 4, 2022 for an Order that, among other things: authorizes the Company to conduct the SISP with the assistance of BMO Nesbitt Burns Inc., as financial advisor, and FTI Consulting Canada Inc., as Court-appointed monitor, in accordance with the terms therein, and approves the execution by the applicable Just Energy Entities of the Stalking Horse Transaction Agreement and the SISP Support Agreement, each of which are described further below. The Just Energy Entities also intend to seek recognition in the U.S. of the SISP Order in their Chapter 15 cases. Subject to the granting of the SISP Order at the motion scheduled for August 17, 2022: If one or more qualified bids are received by September 29, 2022, then Just Energy intends to proceed with an auction to determine the successful bids, subject to the terms of the SISP Procedures. The qualified bid criteria under the terms of the SISP Procedures include, among other things, that bids: provide the necessary Cash Consideration Value to be used together with the Just Energy Entities' cash on hand for the payment of all secured claims and all claims ranking in priority, the Break-Up Fee and a bid increment of no less than $1,000,000, which Cash Consideration Value is estimated to be approximately USD$460,000,000, assuming a closing date of December 31, 2022; do not contain any board or equity holder approval, financing or due diligence conditions; and are accompanied by a cash deposit equal to 10% of the Cash Consideration Value. If the Stalking Horse Purchaser is determined to be the successful bidder at the conclusion of the SISP and the transaction contemplated in the Stalking Horse Transaction Agreement is subsequently approved by the Court, the Stalking Horse Purchaser will own all of the outstanding equity of Just Energy Corp., which will be the new parent company of all of the Just Energy Entities, including the Company, and the Just Energy Entities will continue their business and operations as a going concern. All currently outstanding shares, options and other equity of Just Energy will be cancelled or redeemed for no consideration and without any vote of the existing shareholders. Just Energy has entered into the Stalking Horse Transaction Agreement with the lenders under the Company's debtor-in-possession financing facility, one of their affiliates and the holder of certain assigned secured claims. Key terms of the Stalking Horse Transaction include: The purchase price payable pursuant to the Stalking Horse Transaction is cash in the amount of US$184,857,692.31, plus up to an additional $10 million solely in the event that additional amounts are required to make applicable payments pursuant to the Stalking Horse Transaction Agreement; plus a credit bid of approximately US$230 million plus accrued interest of secured claims assigned to the Stalking Horse Purchaser; plus the assumption of Assumed Liabilities, including up to CAD$10 million owing under the Company's first lien credit facility to remain outstanding under an amended and restated credit agreement. Post-filing claims, the Credit Facility Remaining Debt, claims by energy regulators, and certain other liabilities enumerated in the Stalking Horse Transaction Agreement will continue to be liabilities of the Just Energy Entities following consummation of the Stalking Horse Transaction. Excluded liabilities and excluded assets of the Just Energy Entities will be discharged from the Just Energy Entities pursuant to an Approval and Vesting Order to be sought subject to the Stalking Horse Transaction being the successful bid in the SISP. The consummation of the Stalking Horse Transaction is subject to satisfaction or waiver of a number of conditions precedent set forth in the Stalking Horse Transaction Agreement including, among other things, receipt of all required regulatory approvals and the Court granting an Approval and Vesting Order by October 15, 2022 and the recognition of such Approval and Vesting Order by the U.S. Court under Chapter 15 by November 16, 2022. The outside date for completion of the Stalking Horse Transaction is November 30, 2022, subject to extension in certain circumstances described in the Stalking Horse Transaction Agreement. In the event the Stalking Horse Transaction Agreement is terminated in accordance with applicable terms, payment of a Break-Up Fee as described below is required. Under the Stalking Horse Transaction, no amounts will be available for distribution to the Just Energy Entities' general unsecured creditors, including the Term Loan Lenders. In connection with the Stalking Horse Transaction Agreement, the Just Energy Entities have entered into the SISP Support Agreement with: the Stalking Horse Purchaser, (b) the Company's credit facility lenders, and the Company's largest commodity supplier. Pursuant to the SISP Support Agreement, among other things, the Just Energy Entities have agreed to use commercially reasonable efforts to complete the Stalking Horse Transaction, and the other counterparties have agreed to take actions to support the Stalking Horse Transaction, in each case on the terms and conditions set forth in the SISP Support Agreement. The SISP Support Agreement may be terminated in certain circumstances, including by any of the Just Energy Entities in the event that the board of directors or similar governing body of such entity determines, upon the advice of outside legal counsel and financial advisors, that proceeding with the Stalking Horse Transaction would be inconsistent with the exercise of its fiduciary duties or applicable law; provided that the Just Energy Entities do not have this right to terminate the SISP Support Agreement if no qualified bids are received under the SISP by the applicable deadline or the Stalking Horse Transaction is declared the successful bid in accordance with the SISP Procedures. In the foregoing termination scenario or in the event of Court approval of an alternative transaction, the Just Energy Entities would be required to pay a termination fee to the Stalking Horse Purchaser in the amount of US$14.66 million on closing of an alternative transaction, subject to the granting of the SISP Order.

07:14 EDT Verano Holdings announces opening of MUV Tampa Himes - Verano Holdings announced the opening of MUV Tampa Himes on Friday, August 5, the Company's 54th Florida dispensary and 108th nationwide. MUV Tampa Himes is the fourth MUV retail location in Tampa. "MUV Tampa Himes, our newest storefront in Tampa, brings us to a total of six retail locations throughout Hillsborough County, a community that continues to experience significant growth," said John Tipton, President of Verano. "With Tampa having the third largest population in Florida, we're grateful for the opportunity to reach more medical cannabis patients and welcome them to MUV's patient-centric hospitality."

07:12 EDT Brady appoints Bojarski as President - Identification Solutions - Brady announced the appointment of Olivier Bojarski to the position of President - Identification Solutions, effective August 25, 2022. Bojarski will report to Brady's President and Chief Executive Officer Russell Shaller. Bojarski joins Brady from Belden Incorporated, where he served as Executive Vice President of the Broadband and 5G business.

07:09 EDT Jeld-Wen CEO Gary Michel resigns, Kevin Lilly, named interim CEO - Jeld-Wen announced that its Board of Directors has accepted the resignation of Gary Michel as chair and CEO. Upon his resignation, the Board appointed Kevin Lilly, most recently the company's executive vice president and chief information officer, as interim CEO. In addition, current independent director David Nord, former chairman and CEO of Hubbell Incorporated, was elected chair of Jeld-Wen's Board of Directors. The Board has initiated a comprehensive search for a new CEO, including consideration of both internal and external candidates.

07:07 EDT AMC Networks reports 10.8M streaming subscribers as of June 30 - Grew streaming subscribers 46% to 10.8 million subscribers as of June 30, 2022, from 7.4 million in the prior year, driven by the AMC+ premium streaming bundle launch in Spain and strong content offerings

07:01 EDT DoorDash sees 2023 EBITDA up 'by a modest amount,' says CFO Adarkar - CFO Prabir Adarkar said on the company's quarterly earnings conference call that the company plans to increase annual EBITDA by "a modest amount," and says the core DoorDash ex-Wolt will expand into 2023, even though the consolidated EBITDA "won't grow meaningfully."

06:45 EDT Hut 8 Mining increases Bitcoin holdings by 330 in July - Hut 8 Mining increased its Bitcoin holdings by 330 in the period ending July 31. Hut 8 now has 7,736 Bitcoin in its holdings. The company said, "Our Ethereum mining - for which we receive payment in Bitcoin - generated approximately 10.7% of our total production. Keeping with our longstanding HODL strategy, 100% of the self-mined Bitcoin in July were deposited into custody. Total Bitcoin balance held in reserve is 7,736 as of July 31, 2022 Installed operating capacity was 2.92 EH/s at the end of the month. Hut 8 produced 113.01 BTC/EH in July."

06:39 EDT Vistra sees FY22 ongoing operations adjusted EBITDA $2.81B-$3.31B - The company said, "Vistra is reaffirming its 2022 Ongoing Operations Adjusted EBITDA and Ongoing Operations Adjusted FCFbG1 guidance ranges of $2,810 to $3,310 million and $2,070 to $2,570 million, respectively."

06:35 EDT AdvanSix 'targeting significant earnings growth in 2022' - Outlook: Targeting significant earnings growth in 2022 supported by strength of our integrated business model and diverse end market exposure. Expect continued healthy North America demand for nylon and chemical intermediates. Expect favorable underlying agriculture industry fundamentals to continue; North America ammonium sulfate seasonality expected to drive 3Q22 higher export mix sequentially. Successful integration of U.S. Amines expected to deliver year one earnings accretion. Continue to expect Capital Expenditures to be $95 to $105 million in 2022. Continue to expect pre-tax income impact of planned plant turnarounds to be approximately $32 to $37 million in 2022. "Looking forward, we expect continued healthy North America demand for nylon and chemical intermediates as well as favorable agriculture, nitrogen and sulfur fertilizer industry fundamentals particularly into next year's planting season. While the macro environment continues to be dynamic, we have substantially increased the earnings power of this business. We are well-positioned to fuel future earnings and cash flow performance with continued contributions from high-return growth and cost savings projects, an improved portfolio mix with over $200 million in sales from differentiated products, and strong and disciplined capital deployment. Our core strategies continue to support expectations for AdvanSix's long-term, sustainable performance," concluded CEO Kane.

06:30 EDT ACI Worldwide enters agreement with Japan Card Network - ACI Worldwide announced an agreement with Japan's central domestic payment network, Japan Card Network, Cardnet, to modernize its digital payments infrastructure. The agreement will see ACI work with Cardnet to provide the latest digital payments technology and next-generation solutions to Cardnet's customers.

05:49 EDT Twitter rejects Elon Musk's claims that he was 'hoodwinked' - Twitter on Thursday dismissed Elon Musk's claims in a Delaware court filing that he was "hoodwinked" into signing the deal to buy the social media company, saying that it was "implausible and contrary to fact." "According to Musk, he -- the billionaire founder of multiple companies, advised by Wall Street bankers and lawyers -- was hoodwinked by Twitter into signing a $44 billion merger agreement. That story is as implausible and contrary to fact as it sounds," the filing released by Twitter on Thursday said, adding that "It is just that -- a story, imagined in an effort to escape a merger agreement that Musk no longer found attractive once the stock market -- and along with it, his massive personal wealth -- declined in value." Reference Link